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The importance of chemokine expression on HIV infection has been emphasized by the discovery that infection of CD41
T cells by M-tropic strains of HIV-1 is antagonized by the chemokines RANTES, MIP-1a, and MIP-1b, which are natural
ligands of CCR5, a major coreceptor for macrophagetropic (M-tropic) isolates of HIV-1. Similarly, the CCR2b ligands MCP-1
and MCP-3 inhibit productive infection of PBMCs by both CCR5- and CXCR4-dependent strains of HIV-1, suggesting that
expression of the MCP-1 chemokine may affect HIV infection via signaling through the CCR2 receptor and subsequent
desensitization of the CCR5 and/or CXCR4 signaling pathway. Given the major role played by chemokine receptors in HIV-1
fusion/entry and the regulatory effects of chemokines on HIV-1 infection, we examined the pattern of chemokine gene
expression in HIV-1-infected myeloid cells and in primary monocyte/macrophages. Chronic HIV-1 infection of U937 mono-
cytic cells increased the expression of RANTES, MIP-1a, MIP-1b, and IL-8 chemokine genes, but strongly inhibited
PMA/PHA- and TNFa-induced MCP-1 gene transcription. HIV-1-mediated inhibition of MCP-1 transcription and secretion was
further confirmed in de novo HIV-1-infected U937 cells and correlated with a delay in HIV- and signal-induced NF-kB binding
to the MCP-1 promoter. The inhibition of MCP-1 gene expression may provide a mechanism by which HIV-1 escapes the early
influence of chemokine expression in monocytic cells. © 1999 Academic Press
e
f
1
g
a
a
1
H
m
1
T
S
l
o
m
(
T
t
C
d
o
e
p
1
wINTRODUCTION
Human immunodeficiency virus (HIV) infects a number
f cell types, including CD41 T cells (Gallo et al., 1984),
onocytes (Gartner et al., 1986), and macrophages (Koe-
ig et al., 1986), as well as bone marrow precursor cells
Stanley et al., 1992), both in vivo and in vitro. In contrast
o HIV replication in T lymphocytes, which results in T
ell death, infection of cells of the monocytic lineage
roduces high levels of virus in the absence of signifi-
ant cytopathicity (Roy and Wainberg, 1988; McElrath et
l., 1989), suggesting that infected monocytes/macro-
hages (M/M) may serve as a reservoir for HIV persis-
ence and spread in vivo (Meltzer et al., 1990; Meltzer and
endelman, 1992; Perno et al., 1997). Promonocytic cell
ines such as U937 and THP-1 have been widely used as
n vitro models to investigate HIV-1 infection of M/M,
lthough these cells differ markedly from their in vivo
ounterparts in terms of their susceptibility to different
iral strains (Schuitemaker et al., 1992a; b). U937 cells
ecome susceptible to macrophage-tropic (M-tropic)
IV-1 after treatment with retinoic acid (RA) or phorbol
2-myristate 13-acetate (PMA), agents that induce my-
1 To whom reprint requests should be addressed at Lady Davis
nstitute for Medical Research, 3755 Cote Ste. Catherine, Montreal,
uebec, Canada H3T1E2. Fax: (514) 340-7576. E-mail: mijh@musica.
(cgill.ca.
205loid differentiation and expression of CCR5, a major
usion/entry cofactor for M-tropic HIV-1 (Moriuchi et al.,
998).
HIV infection is initiated by viral envelope glycoprotein
p120 interaction with cell surface CD4, followed by
ssociation with a coreceptor that triggers fusion of viral
nd cellular membranes (Deng et al., 1996; Feng et al.,
996; Doms and Peiper, 1997). Most monocytotropic
IV-1 strains use CCR5 chemokine receptor to enter
acrophages and primary T lymphocytes (Dragic et al.,
996; Raport et al., 1996; Alkhatib et al., 1996), whereas
-tropic HIV-1 strains use CXCR4 (fusin, LESTR, or HUM-
TR) for primary CD41 T lymphocytes and CD41 T cell
ines (Feng et al., 1996; Berson et al., 1996). In addition,
ther chemokine receptors support infection by one or
ore virus strains in vitro, including CCR2b and CCR3
Doranz et al., 1996; Choe et al., 1996; Rucker et al., 1996).
he predominant virus strains isolated early after infec-
ion from asymptomatic, HIV-positive individuals use
CR5 as coreceptor, while viruses that emerge later
uring the course of infection use CXCR4 either in place
f or in addition to CCR5 (Berger et al., 1998).
While coreceptors play a critical role in supporting
ntry of HIV-1 into cells, coreceptors may also influence
ostentry events (Edinger et al., 1997; Chackerian et al.,
997). Interaction of soluble HIV-1 and SIV Env proteins
ith CCR5 and CXCR4 results in receptor signalingDavis et al., 1997; Weissman et al., 1997). Coreceptor
0042-6822/99 $30.00
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206 GE´NIN ET AL.ignaling (coupling, phosphorylation, and internalization)
re not required for Env-mediated membrane fusion or
irus infection of transformed cell lines, but receptor
ignaling mediated either by HIV-1 interaction or by bind-
ng of ligand could influence postentry events of virus
eplication in primary cells such as macrophages
Aramori et al., 1997).
Chemokines are small (8- to 12-kDa) chemoattractant
roteins that constitute the natural ligands for chemokine
eceptors. The b-chemokines RANTES, MIP-1a, and
IP-1b interact with CCR5 (Raport et al., 1996) and the
-chemokine stromal-derived factor-1 (SDF-1) serves as
ligand for CXCR4 (Bleul et al., 1996). Consequently,
hese chemokines can block infection of HIV-1 strains
hat use CCR5 and CXCR4, respectively. For example,
ANTES, MIP-1a, and MIP-1b inhibit infection of CCR5-
xpressing peripheral blood mononuclear cells (PBMCs)
y macrophage-tropic virus, while SDF-1 blocks infection
f CXCR41 HeLa/CD4 cells by the T cell line-adapted
IV-1 LAI (Cocchi et al., 1995; Bleul et al., 1996; Oberlin et
l., 1996). Given these inhibitory effects, increased che-
okine production may function as part of a protective
ost immune response against HIV infection and dis-
ase progression (Cocchi et al., 1995). Thus, b-chemo-
ine gene expression is strongly enhanced in lymph
odes of patients with HIV disease, indicating that cells
ecruited to HIV-infected lymph nodes are likely to inter-
ct with b-chemokines before exposure to virus, since
hese molecules direct mononuclear cell traffic to sites of
nflammation (Tedla et al., 1996; Adams and Lloyd, 1997).
owever, conflicting results have reported different ef-
ects of b-chemokine expression on HIV-1 replication in
DM and tissue macrophages (Dragic et al., 1996; Sim-
ons et al., 1997; Schmidtmayerova et al., 1996; Coffey et
l., 1997).
Given the major role played by chemokine receptors in
IV-1 fusion/entry and the regulatory effects of chemo-
ines on HIV-1 infection, we sought to examine the pat-
ern of chemokine gene expression in HIV-1-infected
onocytic U937 cells and primary monocyte-derived
acrophages (MDM). In uninfected cells, PMA/PHA
reatment induced expression of b-chemokines such as
ANTES, MCP-1, and MIP-1a and b, as well as the
-chemokines IL-8 and g-IP10. Chronic and de novo
IV-1 infection of U937 cells increased the expression of
hese chemokine genes, but strongly inhibited PMA/
HA- and TNFa-induced MCP-1 gene transcript levels
nd MCP-1 protein secretion. HIV infection of U937 re-
ulted in a delayed induction of NF-kB binding to the
CP-1 promoter and correlated with the repression of
MA/PHA- and TNFa-induced MCP-1 transcription. The
nhibition of MCP-1 gene expression suggests a mech-
nism by which HIV-1 may escape the early influence of
hemokine expression in monocytic cells. mRESULTS
ifferential regulation of chemokine gene expression
n chronically infected monocytic cell lines
The aim of this study was to examine the effect of the
IV infection on chemokine gene expression in myeloid
ell lines (U937), monocytes, and MDM. To determine the
attern of chemokine expression in monocytic cell lines,
romonocytic U937 cells were stimulated with PMA/PHA
nd harvested at different times after stimulation. RNA
xtracted from these cells was then subjected to RNase
rotection analysis. Expression levels of the a-chemo-
ines IL-8 and g-IP10, the b-chemokines RANTES, MIP-
a, MIP-1b, MCP-1, and I-309, and the g-chemokine
ymphotactin (Rollins, 1997; Baggiolini et al., 1997) were
etermined and quantified by normalization with L32 and
APDH mRNA levels as internal controls.
In the absence of stimulation, low-level expression of
hemokine RNA was detected in U937 cells (Fig. 1, lane
). PMA/PHA treatment of U937 cells lead to a dramatic
ncrease (.200-fold after 8 h of stimulation) in the ex-
ression of MIP-1a, MCP-1, and IL-8, as well as a modest
ncrease (2- to 10-fold) in RANTES, g-IP-10, and MIP-1b
RNA levels (Fig. 1, lanes 2–7), in agreement with the
nduced expression of MCP-1, MIP-1a, MIP-1b, and IL-8
s observed previously (Biswas et al., 1998). Induction
ppeared to be coordinately regulated and reached a
FIG. 1. Kinetics of chemokine induction in PMA/PHA-stimulated U937
nd U9-IIIB cells. U937 promonocytic and chronically HIV-1-infected
9-IIIB cells were left unstimulated (lanes 1 and 8) or treated with PMA
50 ng/ml) and PHA (10 ng/ml) for 1, 2, 4, 6, 8, and 10 h (lanes 2–7 and
–14). Total RNA extracted (5 mg) from these cells was subjected to
Nase protection assay using a CK5 human chemokine template of the
iboQuant Multi-Probe RPA kit (PharMingen, San Diego, CA). Arrows
ndicate the migrations of labeled fragments protected from RNase
igestion and corresponding either to chemokine mRNA (RANTES,
-IP10, MIP-1b, MIP-1a, MCP-1, and IL-8) or to a control gene mRNA
L32 and GAPDH).aximum at 8 h after stimulation (Fig. 1, lane 6). As
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207REGULATION OF CC CHEMOKINE EXPRESSION BY HIV-1xpected, no mRNA corresponding to T-cell-restricted
ymphotactin or I-309 genes was detected in U937 cells
data not shown).
The effect of HIV-1 infection on uninduced or PMA/
HA-induced expression of chemokine genes was ex-
mined initially using U9-IIIB cells chronically infected
ith the HIV-1 IIIB strain (Fig. 1, lanes 8–14). In uninduced
9-IIIB cells, RANTES and MIP-1a mRNA were upregu-
ated compared to noninfected U937 cells (Fig. 1, com-
are lanes 1 and 8). Stimulation of U9-IIIB cells with
MA/PHA increased MIP-1a, MIP-1b, and IL-8 mRNA
xpression with the same kinetics as observed in U937
ells (Fig. 1, lanes 9–14); the induced levels of chemokine
NA were increased 3- to 4-fold in infected cells com-
ared to uninfected cells, indicating that HIV infection
nhanced chemokine gene expression. Surprisingly, in
IV-infected U9-IIIB cells, MCP-1 mRNA levels were re-
uced dramatically; after 8 h of PMA/PHA stimulation, a
5-fold decrease in MCP-1 mRNA was detected (Fig. 1,
anes 9–14). Similarly, only low-level expression of g-IP10
as observed after PMA/PHA induction in chronically
nfected U9-IIIB cells.
egulation of chemokine expression during de novo
IV infection of U937 cells
De novo infection of U937 cells was performed to
etermine the pattern of chemokine expression during
he course of HIV-1 infection; the progress of infection
as monitored by reverse transcriptase activity (Fig.
A). At different times after infection, cells were
reated with either PMA/PHA or TNFa for 8 h and then
nalyzed for chemokine RNA accumulation. De novo
IV infection of U937 cells differentially modulated
hemokine RNA expression (Fig. 2B); in unstimulated
ells, the level of MCP-1 RNA decreased during the
ourse of infection, whereas constitutive RANTES ex-
ression was not affected by infection (Fig. 2B, lanes
–5). PMA/PHA-induced MCP-1 transcription was in-
ibited significantly after 6 and 8 days of infection (Fig.
B, compare lanes 6, 8, and 9). Residual mRNA levels
ould be due to MCP-1 expression in uninfected cells.
CP-1 transcript levels were restored by day 24; the
pparent decrease was due to lower recovery of RNA
rom 24 day-infected cells, as indicated by the weak
ignals for L32 and GAPDH (Fig. 2B, lane 10). Quanti-
ication of MCP-1 mRNA levels, using L32 and GAPDH
s internal controls, revealed a higher MCP-1/L32
RNA ratio at day 24 than at day 8 (see Fig. 3A). In
ontrast to chronic infection, de novo infection of U937
ells resulted in a significant decrease in PMA/PHA-
nduced MIP-1a, MIP-1b, and RANTES mRNA (Fig. 2B,
anes 6–8). This downregulation presented the same
ransient characteristics as observed for the MCP-1
ene (Fig. 2B, compare lane 6 and lanes 7–10). A
imilar decrease in MCP-1 mRNA levels was obtained (hen HIV-infected cells were stimulated with TNF-a,
lthough mRNA of other chemokines were barely de-
ectable after 8 h of TNF-a stimulation (Fig. 2B, lanes
1–15). To confirm that this downregulation was solely
ue to HIV infection, U937 cells were cultured for 4, 6,
nd 8 days and stimulated or not with PMA/PHA or
NFa for 8 h. No differences in the constitutive or
nduced chemokine expression pattern were observed
uring this period, indicating that the downregulation
hown at early time of infection was specific to HIV-1
FIG. 2. Regulation of chemokine expression during de novo HIV
nfection of U937 cells. U937 myelomonoblastic cells were infected for
h with the HIV-1 strain IIIB at an m.o.i. of 0.3 PFU/ml. (A) At different
ays after infection, the efficiency of infection was monitored by deter-
ination of reverse transcriptase activity in the supernatants of in-
ected cells. Supernatant (50 ml) was centrifuged for 30 min at 3000 rpm
4°C), mixed with reverse transcriptase reaction buffer, and incubated
2 h at 30°C to measure [3H]TTP incorporation into acid-precipitable
ucleic acid. The reverse transcriptase activity (cpm/ml) was normal-
zed according to cell concentration and plotted in a log scale. (B) At
ays 4 (lanes 2, 7, and 12), 6 (lanes 3, 8, and 13), 8 (lanes 4, 9, and 14),
nd 24 (lanes 5, 10, and 15) after infection, 10 3 106 cells were left
nstimulated (lanes 1–5) or treated either with PMA (50 ng/ml) and PHA
10 ng/ml) (lanes 6–10) or with TNFa (10 ng/ml, lanes 11–15) for 8 h.
otal RNA (5 mg) extracted from these cells was subjected to RNase
rotection assay using a CK5 human chemokine template of the Ribo-
uant Multi-Probe RPA kit (PharMingen). For PMA/PHA-stimulated con-
itions (lanes 6–10), a 4-h exposure of the gel is presented, whereas a
6-h exposure of the gel is shown for the unstimulated (lanes 1 to 5)
nd TNFa-stimulated conditions (lanes 11 to 15).data not shown).
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208 GE´NIN ET AL.ownregulation of MCP-1 mRNA and protein levels
n de novo infected U937 cells
Quantification of MCP-1 mRNA levels during HIV in-
ection demonstrated that PMA/PHA-induced transcrip-
ion of MCP-1 was decreased more than threefold after 6
ays of infection compared to levels in infected cells (Fig.
A). Furthermore, uninduced and TNF-a-induced levels
f MCP-1 RNA were also subject to the same downregu-
ation, although the effect was less marked (Fig. 3A). To
FIG. 3. Downregulation of MCP-1 mRNA and protein levels by de
ovo HIV infection of U937 cells. U937 myelomonoblastic cells were
nfected for 2 h with the HIV-1 strain IIIB. (A) Quantification of the RNase
rotection assay shown in Fig. 2B. For each lane, the labeled fragment
rotected from RNase digestion and corresponding to MCP-1 mRNA
as quantified (graph at the top of the figure), using a Scan Jet 4c
ewlett–Packard scanner and NIH Image 1.60 software. The deter-
ined values were normalized according to the L32 mRNA levels and
lotted as MCP-1/L32 mRNA ratios. Similar results were obtained in
hree independent experiments when the MCP-1 mRNA signal was
ormalized according to the GAPDH mRNA. (B) The concentration of
ecreted MCP-1 protein was determined from the supernatants of
ultures (50 ml) of infected U937 treated with PMA/PHA or TNFa, using
he human monocyte chemoattractant protein-1 (hMCP-1) ELISA kit
BioSource Int., Camarillo, U.S.A.).ssess whether the amount of MCP-1 protein was sim- llarly altered in HIV-infected U937 cells, secreted MCP-1
as measured by ELISA in supernatants of HIV-1-in-
ected cells. Concomitant with the decrease in MCP-1
RNA, the amount of MCP-1 secreted by PMA/PHA-
nduced cells decreased throughout HIV infection; by day
, MCP-1 levels were reduced sixfold compared to un-
nfected cells (Fig. 3B). Interestingly, the decreased
CP-1 levels were nearly identical to those measured in
ntreated 8 day-infected cells, indicating that HIV infec-
ion completely abolished the capacity of U937 cells to
ecrete MCP-1 in response to PMA/PHA stimulation.
ecretion of MCP-1 by uninfected and TNF-a-treated
ells was also inhibited by HIV infection until day 8 (Fig.
B). By 24 days of infection, the levels of MCP-1 protein
ere partially restored, as seen at the mRNA level (Figs.
A and 3B). Quantification of RANTES mRNA levels and
easurement of secreted RANTES showed a modest
ecrease (around 50%) of mRNA and a dramatic de-
rease of RANTES secretion in early times—days 4 and
—of HIV infection in PMA/PHA- and TNFa-stimulated
ells (data not shown).
CP-1 transcription is downregulated after in vitro
ifferentiation of primary monocytes
Primary monocytes/macrophages were isolated from
eripheral blood of uninfected individuals and examined
or PMA/PHA-induced chemokine expression. The ex-
ression pattern in primary monocytes was almost iden-
ical to that observed in U937 cells (Fig. 4A, lanes 3 and
). These data indicated that U937 cells reflected the
haracteristics of in vivo primary monocytes, at least in
erms of the regulation of chemokine expression. This
bservation was confirmed by the marked differences
etween primary monocytes and nonadherent lymphoid
ells (Fig. 4A, compare lanes 2 and 5). In contrast to
nstimulated monocytes, which only weakly expressed
hemokine RNA in the absence of stimulation (Fig. 4A,
ane 4), constitutive transcription of RANTES, gIP-10,
IP-1a and b, MCP-1, and IL-8 was observed in lym-
hoid cells (Fig. 4A, lane 1). Furthermore, significant
xpression of lymphotactin—a T-cell-specific chemo-
ine—was detected; also PMA/PHA stimulation of lym-
hoid cells slightly enhanced the mRNA levels of MIP-1a
nd b, but reduced that of MCP-1 (Fig. 4A, compare lanes
and 2).
In vitro culture of primary monocytes resulted in the
ownregulation of PMA/PHA-induced MCP-1 mRNA lev-
ls at 3, 6, and 9 days after seeding, but did not signifi-
antly affect expression of MIP-1a, MIP1-b, and IL-8
enes (Fig. 4, lanes 6 and 7). Interestingly, a significant
ownregulation of RANTES expression was also ob-
erved in primary monocytes after 3, 6, and 9 days of in
itro differentiation (Fig. 4, lanes 4–7). These data indi-
ated that expression of MCP-1 RNA were downregu-ated when primary monocytes were differentiated into
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209REGULATION OF CC CHEMOKINE EXPRESSION BY HIV-1acrophages. A similar observation was made when
937 cells were infected by the HIV-1 IIIB strain for the
ame period of time (data not shown). The similarities in
CP-1 and RANTES inhibition observed after HIV infec-
ion or after monocytic differentiation suggest a common
echanism resulting in MCP-1- and RANTES-specific
epression.
ffect of antioxidant agents on chemokine expression
n monocytic lineages
Chronic infection of myeloid U937 and PLB985 cells
eads to constitutive NF-kB activity, due to enhanced
kBa turnover and increased NF-kB induction (Roulston
t al., 1992; 1993; DeLuca et al., 1996). To assess the
otential role of NF-kB in the coordinated regulation of
hemokine genes, cells were treated with N-acetyl-L-
ysteine (NAC) and pyrrolidinedithiocarbamate (PDTC)—
ntioxidant agents that specifically inhibit the NF-kB in-
uction in a variety of cell types (DeLuca et al., 1998; Lee
t al., 1997). NAC and PDTC treatment of U937 cells
nhibited PMA/PHA-induced transcription of RANTES,
IP-1a, MIP-1b, and MCP-1 and reduced IL-8 gene ex-
ression (Fig. 5, lanes 4–6 of the corresponding panels).
owever, PMA/PHA-induced expression of MIP-1a and
L-8 was less sensitive to NAC or PDTC treatment in
9-IIIB cells than in uninfected U937 cells (Fig. 5, com-
FIG. 4. In vitro differentiation of primary monocytes extracted from
lood. Primary monocytic cells were purified by the adherence sepa-
ation method from PBMCs—extracted from blood by Ficoll separation.
ells from the adherent fraction were cultured for 24 h (lanes 4 and 5)
r 3, 6, or 9 days (lanes 6–8). At days 0 (lane 5), 3 (lane 6), 6 (lane 7),
r 9 (lane 8), cells were treated with PMA (50 ng/ml) and PHA (10 ng/ml)
or 8 h. PMA/PHA-stimulated U937 (lane 3) and unstimulated or PMA/
HA-treated lymphoid cells from the nonadherent fraction (lanes 1 and
) were used as controls. Total RNA (5 mg) extracted from these cells
as subjected to RNase protection assay using a CK5 human chemo-
ine template of the RiboQuant Multi-Probe RPA kit (PharMingen).are lanes 4–6 to 10–12 in each panel). Since NAC and MDTC have been shown to inhibit the induction of NF-kB
y PMA, the upregulation of MIP-1a- and IL-8-induced
ranscription in chronically infected U9-IIIB cells cannot
e explained by sustained NF-kB activity in these cells.
s expected, no effect of NAC or PDTC treatment was
bserved on MCP-1 and g-IP10 expression in U9-IIIB
ells. Similar results were obtained after stimulation of
ninfected and HIV-infected cells by TNFa (data not
hown). The inhibition of PMA/PHA-induced transcrip-
ion of MCP-1 gene expression in U937 cells by NAC and
DTC treatment strongly suggests that activation of
F-kB activity is responsible for induced expression of
hese two genes and that chronic or de novo HIV infec-
ion may lead to decreased or inhibited NF-kB binding
ctivity in U937 cells.
F-kB binding to the A1-kB site of the MCP-1
romoter is inhibited by HIV
The MCP-1 promoter contains in its distal region two
F-kB sites—A1 and A2, located at 22645 to 22626 and
FIG. 5. Effect of antioxidant agents on chemokine expression in
nstimulated or PMA/PHA-stimulated U937 and U9-IIIB cells. U937
romonocytic and chronically HIV-1-infected U9-IIIB cells were un-
reated (lanes 1, 4, 7, and 10) or pretreated with N-acetylcysteine (NAC,
anes 2, 5, 8, and 11) or pyrrolidinedithiocarbamate (PDTC, lanes 3, 6, 9,
nd 12) for 1 h. Cells were then left unstimulated (lanes 1–3 and 7–9)
r treated with PMA (50 ng/ml) and PHA (10 ng/ml) for 8 h (lanes 4–6
nd 10–12) in the continuous presence of antioxidant agents. Total RNA
5 mg) extracted from these cells was subjected to RNase protection
ssay using a CK5 human chemokine template of the RiboQuant
ulti-Probe RPA kit (PharMingen).
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210 GE´NIN ET AL.2616 to 22597, respectively—which are involved in
PA-induced expression of MCP-1 (Ueda et al., 1997).
F-kB binding to the MCP-1 promoter was assessed in
IV-infected U937 cells by EMSA using the A1-kB site of
he MCP-1 promoter as probe. In control U937 extracts,
wo weak NF-kB complexes were detected which re-
cted with anti-p50 antibody (Figs. 6A, lane 1, and 6B,
anes 1–5). Stimulation of U937 cells with PMA/PHA or
NFa resulted in an approximately 10-fold induction of
he two complexes (Fig. 6A, lanes 1, 6, and 11). Complex
ormation was blocked with anti-p50 antibody and was
FIG. 6. Inhibition of induced NF-kB binding activity to the A1-kB site
f the MCP-1 promoter. U937 myelomonoblastic cells were infected for
h with the HIV-1 strain IIIB. (A) Before infection (lanes 1, 6, and 11) or
t days 4 (lanes 2, 7, and 12), 6 (lanes 3, 8, and 13), 8 (lanes 4, 9, and
4), and 24 (lanes 5, 10, and 15) after infection, 5 3 106 cells were left
nstimulated (lanes 1–5) or treated either with PMA (50 ng/ml) and PHA
10 ng/ml) (lanes 6–10) or with TNFa (10 ng/ml, lanes 11–15) for 8 h.
hole cell extracts (10 mg) were subjected to EMSA analysis using
g-32P]ATP-labeled A1-kB probe. Arrows indicate the position of specific
F-kB complexes. (B) Supershift analysis was performed with extracts
rom uninfected (lanes 1–5 and 11–20) U937 cells or cells infected by
IV-1 for 6 days (lanes 6–10) using anti-p50 (lanes 2, 7, 12, and 17),
nti-p65 (lanes 3, 8, 13, and 18), or anti-c-Rel (lanes 4, 9, 14, and 19)
ntibodies with A1-kB probe. Competition was performed in the pres-
nce of a 100-fold excess of unlabeled A1-kB oligonucleotide (lanes 5,
0, 15, and 20). Arrow indicates the position of complex shifted by both
nti-p50 and anti-p65 antibodies.eakly inhibited with anti-p65 and anti-c-Rel (Fig. 6B, banes 11–15 and 16–20). Thus the A1-kB site participates
n PMA/PHA- and TNFa-induced expression of the
CP-1 gene, in agreement with data showing that this
ite of MCP-1 promoter is required for its TPA-induced
xpression (Ueda et al., 1997).
HIV infection of U937 cells resulted in the appearance
f a slower migrating protein–DNA complex, which was
urther identified by supershift analyses as the p65–p50
omplex (Figs. 6A, lanes 2–5, and 6B, lanes 6–10). Inter-
stingly, stimulation of HIV-infected U937 cells with PMA/
HA and TNFa revealed a delay in the appearance of the
50–p65 complex early after infection—days 4 and 6
compare Fig. 6B, lanes 2 and 3, with lanes 7, 8, 12, and
3) and a complete inhibition of the PMA/PHA- or TNFa-
nduced NF-kB complexes identified in control cells (Fig.
A, lanes 6–8 and 11–13). At later times—8 or 24 days—
he HIV-induced NF-kB complex was detected, but not
he PMA/PHA- or TNFa-induced complexes observed in
ninfected cells (Fig. 6A, lanes 9–10 and 14–15). Both the
elayed induction of the HIV-specific NF-kB complex and
he inhibition of the PMA/PHA- and TNFa-induced NF-kB
ctivity correlated with the inhibition of PMA/PHA- and
NFa-induced expression of MCP-1 mRNA observed af-
er 4 and 6 days of HIV-1 infection (Figs. 2B and 3A). An
dentical pattern of inhibition of NF-kB activation and
inding was observed when the A2-kB site of the MCP-1
istal promoter was used as a probe (data not shown),
ndicating the involvement of both sites in MCP-1 regu-
ation.
nhibition of NF-kB binding to the RANTES promoter
To determine if the RANTES promoter may be similarly
egulated by HIV-induced inhibition of NF-kB binding at
arly times after HIV-1 infection, NF-kB activity was as-
essed using the 243 to 230 region of the RANTES
romoter, which contains two adjacent NF-kB sites (Lin
t al., 1999). A similar pattern of PMA/PHA- and TNFa-
nduced NF-kB binding was observed (Fig. 7, lanes 1, 6,
nd 11) and similar inhibitory effects of HIV infection on
F-kB protein–DNA complexes were also detected (Fig.
, compare lanes 2 to 5 with lanes 7 to 10 and 12–15).
his observation suggests that identical mechanisms of
nhibition of NF-kB binding activity may be responsible
or the decrease in PMA/PHA- and TNFa-induced RAN-
ES mRNA expression shown after 4 and 6 days of HIV
nfection (Fig. 2B).
DISCUSSION
The importance of chemokine gene expression during
IV infection has been emphasized by the finding that
nfection of CD41 T cells by M-tropic strains of HIV-1 is
ntagonized by the chemokines RANTES, MIP-1a, and
IP-1b, the natural ligands of CCR5 (Raport et al., 1996).
owever, conflicting data regarding the influence of
-chemokines on HIV-1 replication in MDM and tissue
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211REGULATION OF CC CHEMOKINE EXPRESSION BY HIV-1acrophages have been reported, with observations of
nhancement, inhibition, or no effect (Schmidtmayerova
t al., 1996; Dragic et al., 1996; Simmons et al., 1997;
offey et al., 1997). The dichotomous effects of b-che-
okines on HIV replication appear to depend on whether
onocytes and MDM are exposed to chemokines be-
ore, simultaneously with, or after infection (Kelly et al.,
998). Moreover, enhanced HIV-1 replication following
nhibition of endogenous b-chemokines by neutralizing
ntibodies has been reported (Kinter et al., 1996). The
evels of chemokine expression and secretion therefore
nfluence the ability of HIV-1 virus to replicate into target
ells.
Using U937 monocytic cells and HIV-infected U937
ells as a model of chronic HIV infection, Kelly et al.
eported an increased level of constitutive expression of
he b-chemokines RANTES and MIP-1a (Kelly et al.,
998). Chronic infection of myelomonocytic U937 or
LB985 cells produces constitutive NF-kB activity and
ecent data have shown that chronic and de novo HIV
nfection of monocytic cells results in selective activation
f NF-kB (p50/p65) via the activation of the IKKb subunit
f the recently identified IkBa kinase (IKK) complex (De-
uca et al., 1999; Asin et al., 1999). Since several che-
okine genes are regulated in part by NF-kB, it is likely
hat upregulation of constitutive and induced chemokine
xpression are due to an HIV-mediated increase in
F-kB transactivation in chronically infected cells (re-
iewed in Roulston et al., 1995). Actually, NF-kB has been
FIG. 7. Similar patterns of NF-kB binding activity observed with the
F-kB site of RANTES promoter. U937 myelomonoblastic cells were
nfected for 2 h with the HIV-1 strain IIIB. Before infection (lanes 1, 6,
nd 11) or at days 4 (lanes 2, 7, and 12), 6 (lanes 3, 8, and 13), 8 (lanes
, 9, and 14), and 24 (lanes 5, 10, and 15) after infection, 5 3 106 cells
ere left unstimulated (lanes 1–5) or treated either with PMA (50 ng/ml)
nd PHA (10 ng/ml) (lanes 6–10) or with TNFa (10 ng/ml, lanes 11–15)
or 8 h. Whole cell extracts (10 mg) were subjected to EMSA analysis
sing a [g-32P]ATP-labeled NF-kB RANTES probe. Arrows indicate the
osition of specific NF-kB complexes.hown to constitute a potential activator of RANTES oxpression (Moriuchi et al., 1997) and to be responsible
or the serum- and endotoxin-mediated induction of
IP-1a expression in macrophages (Grove and Plumb,
993). Similarly, TNFa- and PMA-induced expression of
he MCP-1 gene is suggested to be mainly due to NF-kB
ctivation (Freter et al., 1996; Ping et al., 1996; Ueda et al.,
997).
In this paper, we examined chemokine gene expres-
ion during HIV infection of monocytic cell lines and
rimary monocytes/macrophages. PMA/PHA-induced
ranscription levels of MIP-1a and MIP1-b as well as IL-8
enes were increased in chronically HIV-infected U937
ells. The differential effect of HIV infection on chemo-
ine expression was highlighted by the complete inhibi-
ion of PMA/PHA-induced transcription of MCP-1 and
-IP10 in U9-IIIB cells, suggesting that HIV may bypass
ormal PMA/PHA- or TNFa-mediated induction of certain
hemokine genes, such as MCP-1 and to a lesser extent
-IP10. The inhibition of MCP-1 expression was con-
irmed at both mRNA and protein levels, during the
ourse of de novo infection in U937 cells. Interestingly,
nhibition was only transient, with the maximum de-
rease reached at 6–8 days after infection. In contrast to
hronic infection, de novo infection of U937 cells pro-
uced a similar transient downregulation of MIP-1a and
IP-1b transcription, RANTES expression was de-
reased, and PMA/PHA-induced transcription of the IL-8
ene was unaffected. These discrepancies between
hronic and de novo infection of U937 may reflect the in
ivo complexity of HIV infection, the state of monocytic
aturation, and the differentiation state at which the
nfection occurs. Interestingly, the similarities in MCP-1
nd RANTES transcriptional inhibition induced by either
IV infection or in vitro differentiation of monocytes sug-
est a common mechanism that leads to MCP-1- and
ANTES-specific repression, at least in monocytic cells.
inally, our data may provide an explanation of the func-
ional alterations in chemotaxis associated with HIV in-
ection of myeloid cells (reviewed in Roulston et al.,
995).
By EMSA, we showed that HIV infection of U937 cells
ed, at early times after infection, to a delayed induction
f the HIV-specific NF-kB binding complex, as well as to
complete inhibition of PMA/PHA- or TNFa-induced
F-kB binding activity to the NF-kB sites of the MCP-1
romoter. This decrease in DNA binding activity ob-
erved at 4 and 6 days after HIV-1 infection may thus
xplain the repression of PMA/PHA- and TNFa-induced
CP-1 transcription occurring at early times of infection.
he EMSA data also suggest that identical mechanisms
f NF-kB inhibition may be responsible for the decrease
n PMA/PHA- and TNFa-induced RANTES expression at
and 6 days after HIV infection. Furthermore, our results
ssociate the appearance of an HIV-specific NF-kB com-
lex with the increase in MCP-1 and RANTES mRNA
bserved in unstimulated cells or at later times of infec-
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212 GE´NIN ET AL.ion (days 8 and 24). However, other mechanisms, such
s posttranscriptional control, could be involved in virus-
nduced activation or repression of the MCP-1 and/or
ANTES genes, since it has recently been shown that
nduced expression of RANTES by the respiratory syn-
ytial virus (RSV) is mediated by increases in promoter
ctivity as well as stabilization of RANTES mRNA (Koga
t al., 1999).
Transient inhibition of MCP-1 expression in U937 cells
ollowing HIV infection may constitute a novel mecha-
ism by which HIV-1 escapes the influence of MCP-1
xpression and subsequent CCR2 binding on virus entry/
usion or postentry events. Similarly, RANTES expression
s also inhibited by HIV, at least in acute infection. Inter-
stingly, MCP-1 and RANTES are targeted by another
nrelated virus—human cytomegalovirus (HCMV)—
hich encodes a homologue of a CC chemokine recep-
or gene (US28) that is capable of binding MCP-1 and
ANTES (Gao and Murphy, 1994). Depletion of these
hemokines from the medium of HCMV-infected cells
as shown to be partially due to continuous internaliza-
ion of extracellular chemokine by expression of the
S28 protein at the cell surface (Bodaghi et al., 1998).
he observation that MCP-1 accumulates in the cerebro-
pinal fluid of individuals with CMV encephalitis and
ecruits monocytic cells (Bernasconi et al., 1996), thus
ffecting the ability of virus to persist and replicate in the
rain, suggests that inhibiting MCP-1 and RANTES by
S28 is crucial for CMV productive replication in the
rain. Similarly, inhibition of chemokine secretion by
IV-1 may counteract the inhibitory effects of chemo-
ines on viral infection. In contrast to HCMV, downregu-
ation of MCP-1 by HIV-1 is due to transcriptional repres-
ion. Consequently, reexpression of MCP-1 during the
ourse of HIV-1 infection of monocytic cells may alter
irus spread in monocytes/macrophages.
MCP-1 chemokine receptor CCR2 is implicated in
IV infection by virtue of its ability to support infection
y some strains in vitro (Doranz et al., 1996; Rucker et
l., 1996; He et al., 1997). Furthermore, a polymorphism
n the CCR2 chemokine receptor in which Val 64 is
eplaced by Ile (CCR2-64I) has been associated with a
- to 4-year delay in the progression to AIDS (Smith et
l., 1997). The relation between MCP-1 and HIV infec-
ion was further reinforced by the discovery that the
CR2b ligands MCP-1 and MCP-3 inhibited productive
nfection of PBMCs by both the CCR5 and CXCR4
trains of HIV-1 (Frade et al., 1997; Schols et al., 1997).
owever, the basis for the protective effects of CCR2-
4I polymorphism and MCP-1/MCP-3 expression is
urrently unclear since only a few HIV-1 strains use
CR2b to infect CD41 cells (Doranz et al., 1996). Re-
ently, Lee et al. hypothesized that heterologous de-
ensitization of CCR5 and CXCR4 signaling by the
CR2 receptor provides a link that might explain bothhe in vivo effects of the CCR2 gene variant and the pntiviral activity of CCR2 ligands (Lee et al., 1998).
eterologous desensitization of the RANTES response
y MCP-1 was previously reported in human mono-
ytic cells (Charo et al., 1994). HIV-1 env can signal
hrough CCR5 and CXCR4 (Davis et al., 1997; Weiss-
an et al., 1997), and coreceptor signaling, although
ot required for env-mediated fusion or entry, can
nfluence postentry events of virus replication in pri-
ary cells (Aramori et al., 1997). Thus, MCP-1 expres-
ion may affect HIV infection via signaling through the
CR2 receptor and subsequent desensitization of the
CR5 and/or CXCR4 signaling pathway.
HIV-1 Tat protein induces CCR5 and CXCR4 expres-
ion in relation to Tat-enhanced infectivity of M- and
-tropic viruses, notably in monocytes/macrophages
Huang et al., 1998). Furthermore, Tat, which is known to
e chemoattractant for monocytes, has recently been
emonstrated to interact with b-chemokine receptor
CR2 and CCR3, but not with CCR5 and to induce Ca21
luxes in monocytes (Albini et al., 1998). Tat activation of
CR2 may stimulate the recruitment of chemokine ex-
ressing cells toward a productively infected cell, favor-
ng the spread of HIV infection. These findings indicate
hat alterations in b-chemokine expression by HIV-1, and
articularly of MCP-1 and RANTES, is essential for the
stablishment of HIV-1 infection.
MATERIALS AND METHODS
ell culture and isolation of primary monocytes
nd lymphocytes
Myelomonoblastic U937 as well as U9-IIIB cells, in-
ected with HIV-1 strain IIIB, were maintained in RPMI
640 (GIBCO, Life Technologies, Grand Island, NY) sup-
lemented with 10% heat-inactivated fetal bovine serum
GIBCO) and 10 mg/ml of gentamicin (Shering Canada,
ointe-Claire, Canada). Cells were stimulated with either
0 ng/ml of PMA (Sigma Chemical Co., St Louis, MO) and
00 ng/ml of PHA (Sigma) or 10 mg/ml of TNFa (R&D
ystems, Minneapolis, MN). Peripheral blood mononu-
lear cells were obtained from HIV-negative, healthy do-
ors, separated by Ficoll/Hypaque (Pharmacia, Upsalla,
weden) centrifugation as described previously (Conti et
l., 1997), and seeded on FBS-coated plastic tissue cul-
ure plates (Mosier, 1984). After an overnight incubation
t 37°C in RPMI 1640 supplemented with 30% FBS,
onadherent cells, which mainly constitute lymphoid
ells, were removed and cultured in 10% FBS RPMI 1640.
dherent cells were extensively washed and cultured
0% FBS RPMI 1640. At 1, 3, 6, and 9 days, adherent cells
ere recovered and analyzed. We refer to monocytes as
ells processed 24 h after seeding, while 3-, 6-, and
-day cultured adherent cells were considered macro-
hages.
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213REGULATION OF CC CHEMOKINE EXPRESSION BY HIV-1IV infection of U937 and reverse transcriptase
ssay
U937 cells were incubated with concentrated HIV-1
train IIIB, a clone derived from the molecular HXB2D
Fisher et al., 1985) at a m.o.i. of 0.3 (viral concentration
f 106 PFU/ml) in a serum-free medium, for 2 h at 37°C.
fter virus exposure, the medium was replaced. Samples
ere obtained every 2 or 3 days for assay of reverse
ranscriptase (RT) activity. RT activity was determined by
ncubating 50 ml of cell supernatants (precleared by
entrifugation at 3000 rpm for 30 min at 4°C) with a
eaction mixture containing [3H]dTTP (2 Ci/mmol, Amer-
ham, Cleveland, OH) in Tris–HCl (pH 7.9) for 20 h at
7°C as described (Lee et al., 1987). Radiolabeled nu-
leotides were precipitated on GF/A Whatmann filters by
sing cold 10% trichloroacetic acid and 95% ethanol.
ncorporated activity was measured by liquid scintilla-
ion.
NA extraction and RNase protection assay
Total RNA from U937 and U9-IIIB cells was extracted
sing RNeasy Mini kit (QIAGEN, Valencia, CA). RNA from
rimary monocytes/macrophages was prepared as de-
cribed (Ausubel et al., 1989). Briefly, cells were lysed in
guanidium thiocyanate homogenization buffer (4.0 M
uanidium thiocyanate, 0.1 M Tris–HCl, pH 7.5, 1% b-mer-
aptoethanol) and the cell lysate was homogenized by
assage through a syringe. Sodium lauryl sarcosinate
0.5%) was added and the suspension was centrifuged at
000 rpm for 10 min at room temperature. The lysate was
ayered on a cushion of CsCl (5.7 M). RNA of higher
ensity (.1.8 g/ml) than that of other cellular compo-
ents was separated by centrifugation for 24 h at 35,000
pm. The RNA pellet was washed, resuspended in TE/
DS, reprecipitated in ethanol, centrifuged, washed,
ried, and resuspended in sterilized H2O. Total RNA (5
g) was subjected to RNase protection assay using a
K5 human chemokine template of the RiboQuant Multi-
robe RPA kit as recommended by the manufacturer
PharMingen, San Diego, CA). Labeled fragments pro-
ected from RNase digestion and corresponding to
CP-1 mRNA were quantified using the NIH Image 1.60
oftware package. Values were normalized to the L32
housekeeping gene) mRNA levels and plotted as MCP-
/L32 mRNA ratios. Similar results were obtained in
hree independent experiments when the MCP-1 mRNA
ignal was normalized according to the GAPDH mRNA.
LISA detection assay
Concentration of secreted MCP-1 protein was deter-
ined from 50 ml of the supernatants of cell cultures
precleared by centrifugation at 3000 rpm for 30 min at
°C) using the Human Monocyte Chemoattractant Pro-
ein-1 (hMCP-1) ELISA kit (BioSource Int., Camarillo,
.S.A.) as described by the manufacturer. BMSA
Whole cell extracts were prepared as previously de-
cribed (Kwon et al., 1998) and 10 mg was subjected to
MSA by using 32P-labeled probes, DNA binding buffer
10 mM HEPES, pH 7.9, 2% glycerol (v/v), 40 mM KCl, 1
M EDTA, pH 8.0, 0.2 mM MgCl2, 1 mM DTT, 0.05 mM
MSF), 0.2% NP-40, 0.5 mg of BSA, and 1 mg of poly(dI:
C). Incubation was performed for 30 min at room tem-
erature. Oligonucleotides used were (22645 to 22626)
1-kB of MCP-1 promoter, 59-GATCTGGGAACTTC-
AAAGC-39; (22616 to 22597) A2-kB of MCP-1 pro-
oter, 59-AGAGTGGGAATTTCCACTCA-39; and (243 to
30) NF-kB of RANTES promoter, 59-ACTCCCCTTAGGG-
ATGCCCCTCAA-39. The resulting protein–DNA com-
lexes were resolved on 5% polyacrylamide (37.5:1) TBE
.253 gels and exposed for 16 h. To demonstrate the
pecificity of protein–DNA complex formation, a 100-fold
olar excess of unlabeled oligonucleotide was added to
he extracts before adding labeled probe. Supershift
nalysis was performed by preincubating 1 ml of anti-
65, anti-p50, and anti-c-Rel antibodies (Santa Cruz Bio-
echnology Inc.) with extracts and binding buffer for 30
in at 4°C before adding probe.
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